Search bioRxiv⌕ Search

Biology subjects

Oome, D.

Publications and source records attributed to Oome, D..

2 recordsLinked to original sources

Phage-mediated just-in-time circuit amplification and delivery for recombinant expression of toxic proteins

In order to address outstanding challenges in bacterial bioreactor bioprocessing, we have developed an approach that alleviates the need for chemical inducers and selective agents (such as antibiotics), and mitigates leaky expression of the production circuit. More specifically, temperate bacteriophage Lambda ({lambda}) was engineered as a chassis to just-in-time amplify and deliver a production circuit to a wild-type Escherichia coli population. Since the expression of the production pathway is engineered to be dependent on {lambda}s central regulatory switch towards the lysogenic state, {lambda} will first lytically amplify in the background without significantly altering overall bioreactor growth dynamics or gene expression. Only when {lambda} eventually starts outnumbering the host population, its natural switch to lysogeny will actively install and trigger the production circuit. As such, the {lambda} chassis serves as an intrinsic self-amplifying inducer that meanwhile rules out any leaky expression. The impact of the initial phage-to-host ratio on population dynamics and production efficiency was assessed experimentally and through ODE modeling, revealing that it can be used to fine-tune the trade-off between gene dosage and biomass conversion into virions. We demonstrate that this leakproof approach is particularly promising for the expression of toxic proteins such as Benzonase, a highly potent DNase and RNase.

synthetic biology↗

Engineering non-exponential proliferation in Escherichia coli using functionalized protein aggregates

Uncurbed exponential proliferation might not always be required for genetically modified microorganisms, and might even cause unpredictable liabilities in their behavior and impact. We therefore constructed a bacterial chassis that adheres to linear proliferation for a finite number of generations, based on the asymmetric segregation of a gradually declining intracellular protein aggregate that is engineered to produce a conditionally essential metabolite such as cAMP.

synthetic biology↗